Ceftazidime is a third-generation cephalosporin antibiotic used as an active pharmaceutical ingredient. It functions by inhibiting peptidoglycan glycosyltransferase, an enzyme involved in bacterial cell wall synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Ceftazidime?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Ceftazidime dihydrochloride
pharmaceutical raw material
Ceftazidime pentahydrate
pharmaceutical raw material
Cefpiramide
pharmaceutical raw material
Gadoteric acid
pharmaceutical raw material
Miglustat
pharmaceutical raw material
Dantrolene
pharmaceutical raw material
(−)-cathinone hydrochloride
pharmaceutical raw material
The international HS code for Ceftazidime (CAS 72558-82-8) is 2941.90.
2941.90
2941 90 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
ORFOPKXBNMVMKC-DWVKKRMSSA-N
CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]
Sourcing Ceftazidime?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.